PER percheron therapeutics limited

Prof Thomas Voit, DMD expert, interview with Wilsons advisory, page-6

  1. 308 Posts.
    lightbulb Created with Sketch. 863
    @pkeno07
    Thanks saw that..

    Also the PLACEBO comment ..“All patients in other DMD trials on placebo decline at natural history”

    Natural history decline is 8% functional loss per year..

    Also massive was near end when Dr Voit was talking about being 1 of the 4 patent holders for micro dystrophin (Sarepta gene therapy) that for AT LEAST the next 10 yrs there will be combination treatment. Nothing cures the disease.. instead of boys dying at 28 to 30, they will live to 45 or 50..
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.8¢
Change
-0.001(5.88%)
Mkt cap ! $8.699M
Open High Low Value Volume
0.9¢ 0.9¢ 0.8¢ $16.64K 2.010M

Buyers (Bids)

No. Vol. Price($)
24 6525662 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 1987416 4
View Market Depth
Last trade - 15.25pm 18/07/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.